<i>ARID2</i> Deficiency Enhances Tumor Progression via ERBB3 Signaling in <i>TFE3</i>-Rearranged Renal Cell Carcinoma
<i>TFE3</i>-rearranged Renal Cell Carcinoma (TFE3-RCC) is an aggressive subtype of RCC characterized by Xp11.2 rearrangement, leading to TFE3 fusion proteins with oncogenic potential. Despite advances in understanding its molecular biology, effective therapies for advanced cases remain elusive. This...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2024-12-01
|
| Saila: | Current Issues in Molecular Biology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1467-3045/46/12/817 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
